Salem Investment Counselors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$220K Buy
494
+174
+54% +$77.5K 0.01% 357
2025
Q1
$155K Buy
320
+61
+24% +$29.6K 0.01% 385
2024
Q4
$104K Hold
259
﹤0.01% 450
2024
Q3
$120K Hold
259
﹤0.01% 430
2024
Q2
$121K Buy
259
+1
+0.4% +$469 ﹤0.01% 419
2024
Q1
$108K Hold
258
﹤0.01% 439
2023
Q4
$105K Sell
258
-2
-0.8% -$814 ﹤0.01% 433
2023
Q3
$90.4K Buy
260
+2
+0.8% +$695 ﹤0.01% 431
2023
Q2
$90.8K Hold
258
﹤0.01% 433
2023
Q1
$81.3K Buy
258
+58
+29% +$18.3K ﹤0.01% 450
2022
Q4
$57.8K Hold
200
﹤0.01% 494
2022
Q3
$58K Buy
+200
New +$58K ﹤0.01% 458
2022
Q1
Sell
-1,861
Closed -$409K 1113
2021
Q4
$409K Buy
1,861
+22
+1% +$4.84K 0.01% 292
2021
Q3
$334K Sell
1,839
-2
-0.1% -$363 0.02% 285
2021
Q2
$371K Buy
1,841
+1,839
+91,950% +$371K 0.02% 270
2021
Q1
$0 Sell
2
-17
-89% ﹤0.01% 922
2020
Q4
$4K Buy
+19
New +$4K ﹤0.01% 723
2019
Q3
Sell
-209
Closed -$38K 672
2019
Q2
$38K Sell
209
-1,690
-89% -$307K ﹤0.01% 407
2019
Q1
$366K Buy
1,899
+5
+0.3% +$964 0.04% 170
2018
Q4
$314K Sell
1,894
-5
-0.3% -$829 0.04% 164
2018
Q3
$366K Sell
1,899
-235
-11% -$45.3K 0.04% 170
2018
Q2
$363K Hold
2,134
0.03% 168
2018
Q1
$335K Hold
2,134
0.04% 173
2017
Q4
$320K Buy
2,134
+50
+2% +$7.5K 0.03% 179
2017
Q3
$316K Buy
2,084
+1,870
+874% +$284K 0.04% 177
2017
Q2
$28K Buy
+214
New +$28K ﹤0.01% 373